J Biol Chem, Vol. 274, Issue 32, 22428-22436, August 6, 1999
Multiple Structural Domains Contribute to
Voltage-dependent Inactivation of Rat Brain
1E Calcium Channels*
Renée L.
Spaetgens
and
Gerald W.
Zamponi§
From the Department of Pharmacology and Therapeutics, Neuroscience
Research Group, University of Calgary,
Calgary, Alberta T2N 4N1, Canada
 |
ABSTRACT |
We have investigated the molecular determinants
that mediate the differences in voltage-dependent
inactivation properties between rapidly inactivating (R-type)
1E and noninactivating (L-type)
1C
calcium channels. When coexpressed in human embryonic kidney cells with
ancillary
1b and
2-
subunits, the wild
type channels exhibit dramatically different inactivation properties; the half-inactivation potential of
1E is 45 mV more
negative than that observed with
1C, and during a 150-ms
test depolarization,
1E undergoes 65% inactivation
compared with only about 15% for
1C. To define the
structural determinants that govern these intrinsic differences, we
have created a series of chimeric calcium channel
1
subunits that combine the major structural domains of the two wild type
channels, and we investigated their voltage-dependent inactivation properties. Each of the four transmembrane domains significantly affected the half-inactivation potential, with domains II
and III being most critical. In particular, substitution of
1C sequence in domains II or III with that of
1E resulted in 25-mV negative shifts in
half-inactivation potential. Similarly, the differences in inactivation
rate were predominantly governed by transmembrane domains II and III
and to some extent by domain IV. Thus, voltage-dependent
inactivation of
1E channels is a complex process that
involves multiple structural domains and possibly a global
conformational change in the channel protein.
 |
INTRODUCTION |
The influx of calcium through neuronal voltage-gated calcium
channels regulates a wide range of cellular processes, including neurotransmitter release, activation of
Ca2+-dependent enzymes and second messenger
cascades, gene regulation, and proliferation. To date, the primary
structures of at least nine different neuronal Ca2+ channel
1 subunits have been identified.
1C,
1D, and
1F encode L-type channels (1-3);
1B defines N-type channels (4-6);
1A encodes both P- and Q-type channels (7-11);
1G,
1H, and
1I form T-type channels (12, 13);
and
1E probably encodes a component of the
"resistant" current identified in several neuronal preparations
(14-16).
A key mechanism by which these channels achieve the tight regulation of
internal calcium levels is a fast, voltage-dependent inactivation process. Calcium channel inactivation is a critical determinant of the temporal precision of calcium signals and serves to
prevent long term increases in intracellular calcium levels, which are
cytotoxic to neurons (17-19). The inactivation of calcium channels at
presynaptic terminals may also contribute to short term synaptic
plasticity (20). Additionally, cumulative inactivation of neuronal
calcium channels during a train of action potentials can lead to
variable depression of calcium entry depending on the subunit
composition of calcium channels present (21). Unlike the well
characterized "ball and chain" (22-24) and "hinged lid" (25-28) inactivation mechanisms of voltage-dependent
potassium and sodium channels, the molecular mechanisms for
voltage-dependent inactivation in calcium channel proteins
are incompletely understood. A study by Zhang et al. (29)
has revealed that the domain I S6 region is a critical determinant of
the differences in voltage-dependent inactivation
properties observed with marine ray (doe-I)
1E and rabbit brain
1A calcium channels. More recently, several
individual amino acid substitutions throughout the calcium channel
1 subunit, including the domain I-II linker region, the
proximal carboxyl-terminal region, and the S6 regions in domains III
and IV (7, 11, 30-36) have been shown to reduce or abolish
voltage-dependent inactivation. These observations suggest
that voltage-dependent inactivation of calcium channels may
perhaps involve multiple structural elements.
In order to more systematically examine the molecular determinants
governing calcium channel inactivation, we have created a series of
chimerical calcium channel
1 subunits, which combine the
structural features of rapidly inactivating
1E and
noninactivating
1C calcium channels, expressed them
transiently in HEK cells, and assessed their inactivation properties
via patch clamp. Our data indicate that each transmembrane domain
contributes, to varying degrees, to voltage-dependent
inactivation of rat brain
1E calcium channels and that
inactivation probably involves a complex global conformational change
throughout the channel protein. We hypothesize that the molecular
mechanisms underlying fast voltage-dependent inactivation
in neuronal calcium channels may be analogous to the slower C-type
inactivation process common to many types of potassium channels (23,
37, 38).
 |
EXPERIMENTAL PROCEDURES |
Materials
cDNAs coding for wild type rat brain
1E
(rbE-II; GenBankTM accession no. L15453),
1C
(rbC-II; GenBankTM accession no. M67515), and
2-
subunits were kindly donated by Dr. T. P. Snutch. The
1b subunit was provided by Dr. Perez-Reyes. The pEGFP-C1 was donated by Dr. Robert Dunn. Unless stated otherwise, chemical reagents were purchased from Sigma. Restriction enzymes were
obtained from Life Technologies, Inc. and from New England Biolabs.
Site-directed Mutagenesis
Unique restriction enzyme sites were inserted into the
1C and
1E cDNA constructs via
site-directed mutagenesis at exactly complementary positions at the
beginning of the domain I-II (AvrII) and the domain II-III
(SalI) linker regions and about 20 amino acid residues into
the domain III-IV linker region (MluI) as outlined below.
Site-directed Mutagenesis of
1C--
The rbC-II
construct in Bluescript(KS-) was first cut with SalI,
blunted and then religated in order to eliminate two undesired SalI sites in the polylinker and the 5'-untranslated region.
Subsequently, the construct was cut with NheI and
recircularized to temporarily eliminate 2.5 kilobase pairs of coding
region at the 3'-end. This construct was used as the template for all
subsequent rounds of mutagenesis. Using the QuikChange site-directed
mutagenesis kit (Stratagene), the following mutations were created:
silent mutation at bp1 1199 to create an AvrII site; silent mutation at bp 2256 to
generate a SalI site; and silent mutation at bp 2804 to
eliminate an undesired endogenous AvrII site. In order to
create chimeras that involved domain switches at the junction between
domains III and IV, it was necessary to engineer an MluI
site into the cDNA sequence. In rbC-II, this required a nonsilent
mutation at bp 3606 to the corresponding amino acid residue found in
1E (arginine to threonine substitution). Thus, a fourth
round of mutagenesis to create the MluI site was carried
out; however, this particular construct was used only for chimeras
involving transitions between domains III and IV. Because the amino
acid was switched to the complementary
1E residue, the
mutation became silent once the domain IV switch had occurred. For all
other chimeras, the construct lacking the MluI site was used
as the parent channel source. The successful addition/deletion of
restriction sites was first confirmed via restriction digests, and the
complete coding region was sequenced to confirm the absence of errors.
For both constructs, the excised 2.5-kilobase pair NheI
fragment was reintroduced to yield two full-length clones in Bluescript
containing the unique restriction sites (CCCC, CCCC(+MluI)).
CCCC was subcloned into PMT2 (XS) using the KpnI and
NotI sites flanking the 5'- and 3'-ends of the clone, respectively.
Site-directed Mutagenesis of
1E--
Prior to
mutagenesis, rbE-II in Bluescript(SK
) was cut with NotI
and recircularized to eliminate a 200-bp fragment in the 5'-untranslated region, thus leaving a single NotI site at
the 5'-end. The construct was then cut with XhoI and
recircularized to temporarily reduce its size by 1.7 kilobase pairs at
the 3'-end. This construct was used as the template for all subsequent
rounds of mutagenesis. Using the QuikChange kit, the following silent mutations were created: the addition of an AvrII site at bp
890; the addition of a SalI site at bp 1959; and the
addition of an MluI site at bp 4224. Because the
NotI and KpnI flanking sites in rbE-II were in
opposite orientation compared with those flanking the rbC-II insert, it
was necessary to replace the NotI and KpnI sites
flanking rbE-II with KpnI and NotI, respectively,
again using the QuikChange kit. The successful completion of the five rounds of mutagenesis was confirmed via restriction digests, and the
excised 1.7-kilobase pair XhoI fragment was reintroduced to yield the full-length clone EEEE. This construct was completely sequenced from the 5'-end to the first XhoI (bp 5044) site
to ensure that no PCR errors had occurred. The insert was then
subcloned into PMT2 (XS) using KpnI and NotI.
Creation of
1E/
1C Chimeras
CCCE/EEEC--
These chimeras were assembled in Bluescript using
CCCC (+MluI) and EEEE by switching the
MluI-NotI fragments among the two parent
channels. Both chimeras were subsequently subcloned into pMT2 (XS)
using KpnI and NotI. Again, note that in these
two chimeras the nonsilent Mlu I mutation in CCCC (+MluI)
becomes silent.
CCEC--
CCEC was created by replacement of a SalI fragment
between the II-III linker and the 3' pMT2 polylinker of CCCC with the
corresponding fragment of EEEC in pMT2.
EECE--
EECE was created by replacement of a SalI
fragment from EEEE (II-III linker, 3' pMT2 polylinker) with the
corresponding fragment from CCCE in pMT2.
CEEC--
CEEC was created by replacement of an AvrII
fragment between the 5' pMT2 sequence (900 bp 5' to the pMT2
polylinker) and the I-II linker region of EEEC with the corresponding
fragment of CCCC in pMT2.
ECCE--
ECCE was created by replacement of an AvrII
fragment from CCCE (900 bp 5' to the pMT2 polylinker, I-II linker) with
the corresponding fragment from EEEE.
CEEE/ECCC--
Domains I of EEEE and CCCC were swapped via
excision of the AvrII (pMT2, I-II linker) fragments.
EECC/CCEE--
Domains III and IV of EEEE and CCCC were swapped
via excision of the SalI (II-III linker, 3' pMT2 polylinker) fragments.
ECEE--
Domains III and IV of ECCC were replaced via excision
of the SalI (II-III linker, 3' pMT2 polylinker) fragments of EEEE.
CECC--
Domains III and IV of CEEE were replaced via excision
of the SalI (II-III linker, 3' pMT2 polylinker) fragment
from CCCC.
ECEC--
ECEC was created by replacement of the domain III and
IV fragment from ECCC (via SalI digest) with the
corresponding fragment from EEEC.
CECE--
CECE was created by replacement of the domain III and
IV fragment from CEEE (via SalI digest) with the
corresponding fragment from CCCE.
Transient Transfection
Human embryonic kidney (HEK) tSA-201 cells were grown in
standard Dulbecco's modified Eagle's medium, supplemented with 10% fetal bovine serum, 0.5 mg/ml penicillin streptomycin, and 0.4 mg/ml
neomycin. The cells were grown to 85% confluency, split with
trypsin-EDTA, and plated on glass coverslips at 10% confluency 12 h prior to transfection. Immediately before transfection, the medium
was replaced with fresh Dulbecco's modified Eagle's medium, and a
standard calcium phosphate protocol was used to transiently transfect
the cells with cDNA constructs encoding for calcium channel
1,
1b, and
2-
subunits
and green fluorescent protein (7, 7, 7, and 4 µg, respectively).
After 12 h, cells were washed with fresh Dulbecco's modified
Eagle's medium, and the cells were allowed to recover for 12 h.
Subsequently, the cells were incubated at 28 °C in 5%
CO2 for 1-3 days prior to recording.
Electrophysiology
Immediately prior to recording, individual coverslips were
transferred to a 3-cm culture dish containing external recording solution composed of 20 mM BaCl2, 1 mM MgCl2, 10 mM HEPES, 40 mM TEACl, 10 mM glucose, and 65 mM
CsCl (pH 7.2). Whole cell patch clamp recordings were performed using
an Axopatch 200B amplifier (Axon Instruments, Foster City, CA) linked
to a personal computer equipped with pCLAMP version 6.0. Patch pipettes
(Sutter borosilicate glass, BF150-86-15) were pulled using a Sutter
P-87 microelectrode puller and fire-polished using a Narashige
microforge, and they showed a typical resistance of about 3-4
megaohms. The series resistance was typically around 8 megaohms.
Because most currents were smaller than 1 nA at the peak of the current
voltage relation, voltage errors were calculated to be less than 10 mV
in the worst case. For steady state inactivation curves, this has
little effect on the half-inactivation potential for two reasons.
First, the conditioning potential is not affected by voltage errors,
because with the exception of one chimera (ECEE) there was little
current activation during the conditioning pulses. Second, the test
potential used during the recording of steady state inactivation curves (+20 mV) was typically 10-30 mV more positive than the peak of the
I-V relation, resulting in smaller currents and, thus,
smaller voltage errors. Any remaining errors may cause a slight skewing of the shape of the steady state inactivation curve at the initial falling phase but very little effect on the measured half-inactivation potential. Consistent with this notion, for any given channel construct
we found no correlation between half-inactivation potential and current
size. The internal pipette solution contained 105 mM CsCl,
25 mM tetraethylammonium chloride, 11 mM EGTA,
and 10 mM HEPES (pH 7.2). Recordings were made from cells
expressing the green fluorescent protein gene as visualized by a
fluorescence signal. The bath was connected to ground via a 3 M CsCl AGAR bridge. Seals were formed directly in the
external control solution. After gigaseal formation, cells were allowed
to dialyze for 5-10 min before recordings were performed. Unless
stated otherwise, currents were typically elicited from a holding
potential of
100 mV to various test potentials using Clampex software
(Axon Instruments). We observed only negligible leak currents. At
potentials more positive than the reversal potential, outward currents
carried presumably by cesium ions could be observed; however, these did not significantly affect our determination of the reversal potential, because data points close to reversal were not considered for fitting
of macroscopic current-voltage relations.
Data were filtered at 1 kHz and recorded directly onto personal
computer. Data were analyzed using Clampfit (Axon Instruments). All
curve fitting was carried out in Sigmaplot 4.0 (Jandel Scientific). Steady state inactivation curves were fitted to the Boltzman equation, Ipeak (normalized) = C + (1
C)/(1 + exp((V
Vh)
z/25.6)), where V and Vh are
the conditioning and the half-inactivation potential, respectively,
z is a slope factor, and C is the noninactivating fraction. Current-voltage relations were fitted according to the equation Ipeak = (V
Erev)G(1/(1 + exp(Va
V)/S)) where Erev is the reversal potential,
Va is the half-activation potential, G is
the maximum slope conductance, and S is a slope factor that
is inversely proportional to the effective gating charge. Unless stated
otherwise, all error bars are S.E.,
numbers in parentheses displayed in the
figures reflect numbers of experiments, and p
values given reflect Student's t tests.
 |
RESULTS |
Wild type
1C and
1E Calcium Channels
Exhibit Distinct Voltage-dependent Inactivation
Properties--
It is well established that neuronal (L-type)
1C calcium channels undergo little
voltage-dependent inactivation in response to membrane
depolarization. In contrast,
1E channels are among the
most rapidly inactivating high voltage-activated calcium channel isoforms. Fig. 1 illustrates these
intrinsic differences between
1C and
1E
(both coexpressed in HEK cells with ancillary
2-
and
1b subunits). As seen in Fig. 1A,
1E channels inactivate much more rapidly than the
1C isoform, and this difference is maintained over a
large range of test potentials (Fig. 1C). Generally, we
observed some variability in the number of time constants required for
fitting the time course of inactivation of
1E
(i.e. while in the majority of the cases, a single
exponential yielded a satisfactory fit, in some cases two exponentials
were required). Hence, in order to facilitate comparison among the
different channels, the rate of inactivation is reflected, in Fig.
1C and throughout, as the percentage of peak current that
has inactivated over a time course of 150 ms. Note that, because barium
was used as the external charge carrier and due to effective buffering
of intracellular calcium with EGTA, voltage-dependent
inactivation processes are not contaminated by the calcium-sensitive
inactivation process intrinsic to L-type calcium channels (39).

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 1.
Comparison of kinetic properties of wild type
rbC-II and rbE-II channels. Inset, proposed
transmembrane topology of voltage-dependent calcium
channels. Transmembrane domains of the parent 1C channel
are depicted in black. The four-letter code (CCCC, EEEE)
refers to the origin of the four individual transmembrane domains.
A, representative whole cell current traces
(IBa) of rbC-II (upper panel) and
rbE-II (lower panel) in 20 mM Ba2+.
Currents were elicited by a 250-ms step depolarization to +10 mV from a
holding potential of 100 mV. The traces were leak-subtracted on line
using a p/5 protocol. Note that 1E
inactivates much more rapidly than 1C. B,
representative current-voltage relations of rbC-II (upper
panel) and rbE-II (lower panel) in 20 mM
Ba2+ from a holding potential of 100 mV. The
I-V plots were fitted as outlined under "Experimental
Procedures." The half-activation potential of 1E was
typically about 10 mV more negative than that of 1C.
C, voltage dependence of the inactivation rates (as
determined by the fraction of current inactivated during the course of
a 150-ms test depolarization) for rbC-II (circles,
n = 9) and rbE-II (triangles,
n = 11). D, comparison of steady state
inactivation properties of rbC-II (circles,
n = 9) and rbE-II (triangles,
n = 14). Peak current amplitude was measured
immediately subsequent to a 5-s conditioning potential. The data were
fitted using the Boltzman equation. The half-inactivation potentials
obtained from the fits were 16 mV (z = 3.0) and 58
mV (z = 3.1), respectively, for rbC-II and rbE-II.
Error bars reflect S.E.
|
|
In addition to their rates of inactivation, the wild type channels also
exhibited pronounced differences in their half-inactivation potentials,
with
1E inactivating at potentials about 40 mV more negative than
1C (Fig. 1D). In contrast, at
least with 20 mM barium as the charge carrier, the
half-activation potentials (estimated from Boltzman fits to current
voltage relations) of the two wild type channels differed by only
about 10 mV (Fig. 1B; see also Table
I). Overall, the differences between the
inactivation properties of the two wild type channels are sufficiently
large to permit a chimerical approach toward the molecular
identification of the underlying structural determinants.
View this table:
[in this window]
[in a new window]
|
Table I
Activation and inactivation properties of wild type and chimeric
calcium channels
Values were obtained via Boltzman fits of steady state inactivation
curves (Fig. 2) and macroscopic current-voltage relations. Note that
there is no correlation between half-activation and half-inactivation
potentials. Current-density measurements obtained at the peak of the
current voltage relation reveal variable levels of expression among the
chimeras.
|
|
All Four Transmembrane Domains Contribute to Steady State
Inactivation--
To investigate the molecular mechanism underlying
these differences in voltage-dependent inactivation
properties, we constructed a series of 14 chimeras between wild type
1C and
1E calcium channels. Each chimeric
construct is formed via combination of the four major transmembrane
domains of the two parent channels (see Fig.
2). As described in more detail under
"Experimental Procedures," the chimeras were designed such that
switches occurred immediately after the end of the S6 segments in
domains I and II and about 20 amino acids past that of domain III, and
thus each domain remains associated with the preceding cytoplasmic linker region. Of the 14 chimeras, nine constructs were found to form
functional calcium channels when expressed in HEK cells.

View larger version (43K):
[in this window]
[in a new window]
|
Fig. 2.
Nomenclature and steady state inactivation
properties of C-E chimeras. Transmembrane topology is shown of the
chimeric calcium channel constructs, indicating the nomenclature used
throughout. The chimeras were coexpressed with 2- and
1b subunits. Mean steady state inactivation curves and
representative current traces are shown for each chimera. The
experimental conditions were as outlined in Fig. 1. Error
bars represent S.E. The data were fitted with the Boltzman
equation.
|
|
Fig. 2 depicts representative current traces and ensemble steady state
inactivation curves for each of the nine functional chimeras. In each
case, the voltage dependence of steady state inactivation could be
nicely described with a Boltzman relation. Several of the chimeras, as
well as the wild type
1C channels did not inactivate
completely during the 5-s conditioning pulse, and hence the Boltzman
fit was modified to incorporate this noninactivating fraction (see
"Experimental Procedures"). The half-inactivation potentials and
slope factors obtained from these fits (see also Table I) and the
shapes of the current waveforms (Fig. 2) were consistent with what one
might have expected from our observations with the two wild type
channels. Chimera ECCC exhibited somewhat shallow voltage dependences
of both inactivation and activation (Table I, Fig. 2).
Fig. 3A compares the
half-inactivation potentials of the nine chimeras to the wild type
channels in form of a bar graph. Upon examination
of Fig. 3A, two observations can be made. First, no single
domain switch appears to be able to confer the entire steady state
inactivation properties from one parent channel to another. Instead, a
continuous spectrum of half-inactivation potentials spanning the range
between the two wild type channels was evident. Second, two of the
chimeras (CEEC, CCCE) exhibited half-inactivation potentials outside of
that range, indicating that some of the individual domains of a
particular parent channel may perhaps exert opposing effects on the
position of the steady-state inactivation curve along the voltage
axis.

View larger version (35K):
[in this window]
[in a new window]
|
Fig. 3.
Contribution of individual transmembrane
domains to steady state inactivation. A, comparison of
half-inactivation potentials for wild type and chimerical calcium
channels. In each case, steady state inactivation curves from
individual experiments were fitted separately, and the means and S.E.
are plotted. Numbers in parentheses reflect
numbers of experiments. B, replacement of the
1C sequence in domain I with that of 1E
mediates a moderate (10-15-mV) hyperpolarizing shift in
half-inactivation potential in three out of four pairs of constructs.
C and D, replacement of the 1C
sequences in either domain II or domain III with those of
1E mediates a strong (20-25-mV) hyperpolarizing shift
in half-inactivation for all chimeras tested. E, replacement
of the 1C sequence in domain IV with that of
1E produces a depolarizing shift in half-inactivation
potential. In each case, an asterisk denotes transitions for
which there is a significant shift in Vh
(p < 0.05). The numbers in
parentheses reflect the ratios of the changes in
half-activation potential to the change in half-inactivation potential
for each pair of chimeras.
|
|
From the graph in Fig. 3A, it is difficult to assess the
effects of individual transmembrane domain switches on
half-inactivation potential. Hence, in order to isolate the individual
contributions of each of the four transmembrane domains to the overall
voltage dependence of inactivation, the data of Fig. 3A were
divided into individual pairs of chimeras in which only a single domain
was exchanged. Fig. 3B examines the effect of replacement of
the
1C sequence in domain I with the corresponding
sequence from
1E. As evident from the figure,
three out of the four chimera pairs examined exhibited a 10-15-mV
negative shift in half-inactivation potential when domain I contained
the
1E sequence. Upon replacement of the
1C sequence in either domain II or III with that of
1E, a large hyperpolarizing shift of ~20 mV was
observed in every case. Thus, structures residing within each of the
first three domains contribute to the more negative half-inactivation
potential seen with wild type
1E channels. Surprisingly,
when the same type of analysis was carried out for substitutions in
domain IV, the opposite effect was observed, with
1E
domain IV mediating a depolarizing shift in half-inactivation potential
when replacing
1C sequence. These data indicate that all
four transmembrane domains contribute to steady state inactivation
properties of voltage-dependent calcium channels, and
furthermore, that the absolute value of the half-inactivation potential
of
1E channels is determined through an equilibrium
formed by hyperpolarizing and depolarizing structural elements.
Half-inactivation Potential Shifts Are Not Correlated with
Activation Effects--
It is known for sodium and potassium channels
that inactivation can be tightly coupled to activation. Thus, the above
conclusions are somewhat complicated by the notion that not all of the
chimeras exhibited identical half-activation potentials (see Table I). The wild type channel differed by less than 10 mV in their
half-activation potentials, and yet they exhibited a greater than 40 mV
difference in their half-inactivation potentials. Furthermore, when
examining the data presented in Table I, one can identify two clusters of constructs with half-activation potentials of about
21 mV (EEEE,
EECC, CCEC, CCEE, ECEE) and about
12 mV (CCCC, CEEC, CECC, ECCC),
respectively, and yet, within each of these clusters, the half-inactivation potentials varied by as much as 35 and 50 mV, respectively. Overall, these considerations suggest that the distinct activation potentials of the channels are not correlated with the
observed differences in inactivation properties. Nonetheless, it is
possible that in some cases the activation effects might skew the
absolute inactivation potential changes induced by domain swapping. To
assess the extent of any putative contamination by activation effects,
we calculated the ratio of the change in half-activation potential to
the change in half-inactivation potential for each pair of chimeras
(see numbers in parentheses, Fig. 3B).
A value of 1 indicates that the change in half-inactivation potential parallels the changes in half-activation potential in magnitude, a
value near 0 indicates that there is only little if any contamination by activation effects, and a negative value reflects a scenario in
which a domain switch resulted in opposite shifts in half-activation and half-inactivation potentials. As seen from Fig. 3, in only two out
of 15 cases did the index approach 1, and only four additional chimera
pairs displayed ratios greater than 0.1. It is also noteworthy that
chimera CEEC differed from the wild type
1C channels by only 4 mV in half-activation potential, while exhibiting a
half-inactivation potential that was 55 mV more negative, thus further
supporting the notion that domains II and III carry the bulk of the
voltage dependence of inactivation. Overall, these considerations
suggest that for the majority of chimera pairs, differences in
voltage-dependent activation properties could not account
for the observed changes in half-inactivation potentials.
We did not systematically examine the effects of individual domains on
half-activation potential, because the difference between the two wild
type channels was relatively small (<10 mV), and perhaps with the
exception of
1E domain III, which tended to shift the
half-activation potential into the negative direction (see Table I),
none of the individual transmembrane domains appeared to have a clear
cut effect on activation range. We suspect that even with more accurate
tail current protocols (rather than relying on fits to macroscopic
current-voltage relations), we would be unable to attribute the
distinct activation ranges of the two wild type channels to individual
transmembrane domains.
Transmembrane Domains II, III, and IV Determine Inactivation
Rates--
To determine the effects of domain swapping on the rate of
inactivation, we compared inactivation of wild type and chimeric calcium channels by using the ratio of peak current to the current observed at the end of a 150-ms test depolarization as a single measure
of all voltage-dependent inactivation processes. Fig. 4 depicts the percentage of inactivation
that occurred over 150 ms for three different test pulses (0, +10, and
+20 mV). Similar to what was observed with the half-inactivation
potentials, the inactivation rates of the individual chimeras formed a
continuum within the range spanned by the two wild type channels.
Overall, this indicates that the rate of inactivation may also be
determined by multiple structural domains.

View larger version (39K):
[in this window]
[in a new window]
|
Fig. 4.
Inactivation rates for wild type and chimeric
calcium channels. Inactivation rates of wild type and chimeric
calcium channels, reflected as the percentage of peak current that has
inactivated during a 150-ms test pulse, are shown for three different
test potentials (0, 10, and 20 mV). Error bars
denote S.E.; numbers in parentheses denote the
numbers of experiments. Inactivation rates observed with the chimeras
are widely distributed between those seen with the wild type
channels.
|
|
Fig. 5 examines the role of each
individual transmembrane domain in determining the rate of
inactivation. As seen from Fig. 5A, in only one out of four
cases did exchanges of domain I exert a significant effect, suggesting
that domain I does not contribute in a substantial manner to the
differences in inactivation rate between rat brain
1C
and
1E channels. In contrast, in seven out of eight
cases, replacing
1C sequences in domains II or III with
those corresponding to
1E mediated increases in
inactivation rate by 2.5- and 4-fold, respectively. Consistent with
what we had observed with steady state inactivation, domain IV of
1E actually slowed the rate of inactivation (by
2.5-fold). This behavior is further illustrated in Fig. 5 with the
current records and voltage dependences of the inactivation rates of
selected chimera pairs. Insertion of domain I of
1E into
the wild type
1C channel had little effect on current
waveform or on the magnitude and voltage dependence of the rate of
inactivation. Insertion of domain II or III of the wild type
1E channel into
1C mediated a significant speeding of inactivation at all test potentials (Fig. 5, B
and C, insets). In fact, there was no significant
difference in inactivation rate between chimeras CCEC and the wild type
1E channel at any of the test potentials used indicating
that domain III might be perhaps be the most critical determinant of
inactivation rate. Finally, in further support of the idea that domain
IV of
1E slows inactivation, the CCEE chimera
inactivated significantly more slowly than CCEC at all potentials
tested.

View larger version (38K):
[in this window]
[in a new window]
|
Fig. 5.
Contribution of individual transmembrane
domains to inactivation rate. A, exchanging domain I
has little effect on inactivation rate. B and C,
replacement of 1C sequence in domain II or III with the
corresponding 1E sequence mediates a substantial
increase in the rate of inactivation. D, replacement of
1C sequence in domain IV with that of 1E slows the
rate of inactivation. Inactivation rates for each construct in Fig. 5
were measured at +20 mV and were taken from Fig. 4. The
asterisks denote statistically significant changes in
inactivation rates (p < 0.05). Insets,
representative whole cell current records illustrating the effects of
single domain switches on inactivation rates (step depolarizations to
+10 mV). Current traces are scaled to the same peak amplitude to allow
for comparison of inactivation rates. The voltage dependences of the
inactivation rates for a number of experiments are depicted
below the current records.
|
|
Overall, our data implicate multiple transmembrane domains in the
overall voltage-dependent inactivation process of neuronal
1E calcium channels, with domains II and III
accounting for the bulk of the effect.
 |
DISCUSSION |
Ca2+ Channel Inactivation Is Fundamentally Different
from That of Na+ and K+ Channels--
The
molecular mechanisms of fast voltage-dependent inactivation
of voltage-dependent sodium and potassium channels are well understood. In Shaker K channels, fast inactivation occurs via physical
occlusion of the pore by a cluster of about 20 amino acid residues at
the amino terminus of the
1 subunit (22, 40). Due to the
tetrameric structure of these channels, the presence of four identical
inactivation particles has been proposed (41). In
voltage-dependent sodium channels, fast inactivation
appears to be caused by occlusion of the pore by three hydrophobic
residues (Ile, Phe, and Met) located in the domain III-IV linker region of the sodium channel
1 subunit (26).
Voltage-dependent calcium channels do not contain analogous
structural elements, and no evidence for a pore blocking mechanism has
been presented. Zhang et al. (29) have provided compelling
evidence that the differences between the inactivation rates of marine
ray
1E and rabbit brain
1A channels can
be exclusively located to the domain I S6 region. However, more
recently, individual point mutations in the domain I-II linker region
(7, 11, 31, 35) and the S6 regions of domains III and IV (32-34) have
been shown to attenuate or abolish voltage-dependent
inactivation of
1A calcium channels, perhaps suggesting
the possibility that inactivation of neuronal calcium channels might
involve a more diffusely located effect.
Here, we have systematically investigated the roles of each of the four
transmembrane domains in voltage-dependent inactivation of
1E channels. Our chimeric approach was designed to be
constructive; i.e. our goal was to confer the inactivation
properties from a rapidly inactivating channel onto a relatively
noninactivating one rather than simple destruction of inactivation.
However, while we could confer certain aspects of
voltage-dependent inactivation of
1E onto
1C channels through insertion of individual domains, we
were unable to attribute the mechanism underlying
voltage-dependent inactivation to a single transmembrane
domain. Instead, our data indicate that all four transmembrane domains
contribute to varying degrees to fast inactivation. The overall
half-inactivation potential appears to be determined through an
equilibrium between hyperpolarizing (
1E domains I, II,
and III) and depolarizing (
1E domain IV) elements.
Similarly, the differences in inactivation rate between the two wild
type channels appeared to involve predominantly domains II and III,
with some contribution from domain IV. Thus, consistent with previous
suggestions, the molecular mechanisms that mediate fast inactivation of
voltage-dependent calcium channels appear to differ
fundamentally from those observed with other type of voltage-gated
cation channels.
Putative Effects of Differential Activation Properties--
In
principle, it is possible that some of the differences in
half-inactivation potentials observed with the chimeric calcium channels might be secondarily due to intrinsic differences in their
activation properties. In 20 mM barium, we observed an
approximate 10-mV difference in the half-activation potentials of wild
type
1E and
1C channels. In contrast,
their difference in half-inactivation potential is more than 4-fold
larger. Furthermore, with the exception of two out of 15 chimera pairs,
we found no correlation between shifts in half-activation and
half-inactivation potentials resulting from the switching of individual
or multiple domains, suggesting that changes in half-activation
potential cannot account for our observations and that the effects
observed with our chimeras are indeed due to structural changes in the
voltage-dependent inactivation machinery.
The effects of individual domain exchanges on the inactivation rate
were examined at the same test potential (+20 mV). Because the rate of
inactivation may be coupled to channel activation, any variability in
half-activation potential among the chimeras/wild type channels might
affect the comparison of inactivation rates measured at a single
arbitrary test potential. However, this variability in half-activation
potential was fairly small (nine of the 11 chimeras activated within a
10-mV window), and thus, given the shallow voltage dependences of the
inactivation rates, our interpretations are not likely to be affected.
Comparison with Previous Work--
At first glance, our data
appear to contradict those of Zhang et al. (29). However,
two issues must be taken into consideration. First, wild type
1E and
1C channels exhibit much more
pronounced differences in inactivation rate and in half-inactivation
potential compared with the channels used by Zhang et al.
(29) to create their chimeras (i.e.
1E and
1A, which are phyllogenetically quite closely related).
Thus, it is possible that both parent channels may carry similar
"inactivation" motifs in domains II, III, and IV but differ
predominantly in domain I. In our case, due to the lower degree of
overall homology shared by
1E and
1C
channels, the regions critical for inactivation might perhaps be more
divergent, thus revealing the contributions of additional domains to
the overall inactivation process. A second fundamental difference
between the present study and that of Zhang et al. lies in
the type of transient expression system used, with Zhang et
al. (29) using Xenopus oocytes as compared with the HEK
cells in our experiments. It is well established that the type of host system frequently affects the functional and pharmacological properties of transiently expressed ion channels (e.g. Ref. 42), and it will be interesting to examine the properties of our chimeras in
Xenopus oocytes. Finally, our data do support some
contribution of domain I in the overall inactivation properties, since
substitution of
1C sequence in domain I with that
corresponding to
1E mediated a 10-15-mV negative shift
in half-inactivation potential.
Two groups have pinpointed individual amino acid residues in the domain
I-II linker as critical determinants of voltage-dependent inactivation. An alternative splice variant of the rat brain
1A channel that carries a single valine insertion in the
domain I-II linker completely lacks voltage-dependent
inactivation (7, 11, 31). Herlitze et al. (35) identified a
single amino acid residue in the domain I-II linker of
1A that can confer positive inactivation properties onto
L-type calcium channels. In the present study, the domain I-II linker
was always associated with domain II. Thus, although Zhang et
al. (29) showed that exchanging the I-II linker region between
doe-I and
1A channels did not affect inactivation rate,
we cannot rule out that the effects that we attribute to "domain
II" may be contained, in part, in the domain I-II linker rather than
the actual domain II region per se. The same consideration
applies in principle to domain III and the carboxyl-terminal region.
Ultimately, swapping of individual cytoplasmic linker regions will be
required to elucidate any putative contributions of the cytoplasmic
linkers to voltage-dependent inactivation properties.
What Might Be the Molecular Mechanism of Fast Ca2+
Channel Inactivation?--
Our observation that each of the four
transmembrane domains appeared to affect voltage-dependent
inactivation might suggest that calcium channel inactivation involves a
complex global conformational change in the channel protein. Most of
the structures or amino acid residues that have been linked to changes
in voltage-dependent inactivation of various types of
calcium channels have been located to the S6 regions in domains I, III,
and IV (29, 32-34, 43), or to cytoplasmic regions directly linked to
these S6 segments such as the domain I-II linker or the
carboxyl-terminal region (36, 44). In addition, cytoplasmic proteins
such as ancillary
subunits and syntaxin that physically bind to the
domain I-II linker (45) and II-III linker regions, respectively, have
been shown to affect voltage-dependent inactivation
properties. In view of our current understanding of the slower C-type
inactivation process in certain types of voltage-dependent
potassium channels (46-51), we hypothesize that
voltage-dependent inactivation of calcium channels could
perhaps involve a physical constriction of the pore. Similar to what
has been proposed to occur during C-type inactivation of potassium
channels, the cytoplasmic ends of the S6 segments might come together
to form an inverted teepee structure during inactivation, thereby
preventing the passage of permeant ions through the pore. Such a
mechanism could account for the previously reported mutagenesis data in
both the S6 regions and the associated linker regions as well as for
the effects of protein interactions with the linker regions. For
example, the structural changes in the linker regions might affect the
mobility or flexibility of the associated S6 regions and thus the
overall inactivation properties. Furthermore, in such a model, one
would expect to observe some contribution from each transmembrane
domain as reported here. Hence, while we cannot rule out the
possibility that the four transmembrane domains might cooperatively
form a docking site for a yet to be identified inactivation gate
particle, a mechanism similar to that proposed to underlie C-type
inactivation of potassium channels is an attractive possibility.
Construction of additional chimeras and/or site-directed mutagenesis
will be required, however, to further support such a hypothesis.
Overall, irrespective of the detailed molecular mechanisms involved,
our data are consistent with the notion that
voltage-dependent inactivation of
1E calcium
channels is complex process that involves multiple structural domains
and thus differs fundamentally from fast inactivation of sodium and
potassium channels.
 |
ACKNOWLEDGEMENTS |
We thank Dr. Terry Snutch for providing wild
type calcium channel cDNAs and Dr. William Catterall for comments
on the data.
 |
FOOTNOTES |
*
This work was supported in part by operating grants from the
Heart and Stroke Foundation of Alberta & Northwest Territories and from
the Medical Research Council of Canada (MRC) and by an equipment award
from the Canada Foundation for Innovation.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Recipient of an Alberta Heritage Foundation for Medical Research
(AHFMR) studentship.
§
Recipient of faculty Scholarships from the MRC, the AHFMR, and the
EJLB Foundation. To whom correspondence should be addressed: Dept. of
Pharmacology and Therapeutics, University of Calgary, 3330 Hospital Dr.
NW, Calgary, Alberta T2N 4N1, Canada. Tel.: 403-220-8687; Fax:
403-283-8731; E-mail: Zamponi@acs.ucalgary.ca.
 |
ABBREVIATIONS |
The abbreviation used is:
bp, base pair(s).
 |
REFERENCES |
| 1.
|
Williams, M. E.,
Feldman, D. H.,
McCue, A. F.,
Brenner, R.,
Velicelebi, G.,
Ellis, S. B.,
and Harpold, M. M.
(1992)
Neuron
8,
71-84[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Tomlinson, W. J.,
Stea, A.,
Bourinet, E.,
Charnet, P.,
Nargeot, J.,
and Snutch, T. P.
(1993)
Neuropharmacology
32,
1117-1126[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Bech-Hansen, N. T.,
Naylor, M. J.,
Maybaum, T. A.,
Pearce, W. G.,
Koop, B.,
Fishman, G. A.,
Mets, M.,
Musarella, M. A.,
and Boycott, K. M.
(1998)
Nat. Genet.
19,
264-267[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Dubel, S. J.,
Starr, T. V.,
Hell, J.,
Ahlijanian, M. K.,
Enyeart, J. J.,
Catterall, W. A.,
and Snutch, T. P.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
5058-5062[Abstract/Free Full Text]
|
| 5.
|
Williams, M. E.,
Brust, P. F.,
Feldman, D. H.,
Patthi, S.,
Simerson, S.,
Maroufi, A.,
McCue, A. F.,
Velicelebi, G.,
Ellis, S. B.,
and Harpold, M. M.
(1992)
Science
257,
389-395[Abstract/Free Full Text]
|
| 6.
|
Fujita, Y.,
Mynlieff, M.,
Dirksen, R. T.,
Kim, M. S.,
Niidome, T.,
Nakai, J.,
Friedrich, T.,
Iwabe, N.,
Miyata, T.,
Furuichi, T.,
Furutama, D.,
Mikoshiba, K.,
Mori, Y.,
and Beam, K. G.
(1993)
Neuron
10,
585-598[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Bourinet, E.,
Soong, T. W.,
Zamponi, G. W.,
Stea, A.,
Nargeot, J.,
and Snutch, T. P.
(1996)
Soc. Neurosci. Abstr.
22,
343
|
| 8.
|
Mori, Y.,
Friedrich, T.,
Kim, M. S.,
Mikami, A.,
Nakai, J.,
Ruth, P.,
Bosse, E.,
Hofmann, F.,
Flockerzi, V.,
Furuichi, T.,
Mikoshiba, K.,
Imoto, K.,
Tanabe, T.,
and Numa, S.
(1991)
Nature
350,
398-402[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Sather, W. A.,
Tanabe, T.,
Zhang, J. F.,
Mori, Y.,
Adams, M. E.,
and Tsien, R. W.
(1993)
Neuron
11,
291-303[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Stea, A.,
Tomlinson, W. J.,
Soong, T. W.,
Bourinet, E.,
Dubel, S. J.,
Vincent, S. R.,
and Snutch, T. P.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
10576-10580[Abstract/Free Full Text]
|
| 11.
|
Sutton, K. G.,
Zamponi, G. W.,
Bourinet, E.,
Soong, T. W.,
and Snutch, T. P.
(1998)
Soc. Neurosci. Abstr.
24,
21
|
| 12.
|
Cribbs, L. L.,
Lee, J. H.,
Yang, J.,
Satin, J.,
Zhang, Y.,
Daud, A.,
Barclay, J.,
Williamson, M. P.,
Fox, M.,
Rees, M.,
and Perez-Reyes, E.
(1998)
Circ. Res.
83,
103-109[Abstract/Free Full Text]
|
| 13.
|
Perez-Reyes, E.,
Cribbs, L. L.,
Daud, A.,
Lacerda, A. E.,
Barclay, J.,
Williamson, M. P.,
Fox, M.,
Rees, M.,
and Lee, J. H.
(1998)
Nature
391,
896-900[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Soong, T. W.,
Stea, A.,
Hodson, C. D.,
Dubel, S. J.,
Vincent, S. R.,
and Snutch, T. P.
(1993)
Science
260,
1133-1136[Abstract/Free Full Text]
|
| 15.
|
Williams, M. E.,
Marubio, L. M.,
Deal, C. R.,
Hans, M.,
Brust, P. F.,
Philipson, L. H.,
Miller, R. J.,
Johnson, E. C.,
Harpold, M. M.,
and Ellis, S. B.
(1994)
J. Biol. Chem.
269,
22347-22357[Abstract/Free Full Text]
|
| 16.
|
Tottene, A.,
Moretti, A.,
and Pietrobon, D.
(1997)
J. Neurosci.
16,
6353-6363[Abstract/Free Full Text]
|
| 17.
|
Choi, D. W.
(1988)
Trends Neurosci.
11,
465-469[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Orrenius, S.,
McConkey, D. J.,
Bellomo, G.,
and Nicotera, P.
(1989)
Trends Pharmacol. Sci.
10,
281-285[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Orrenius, S.,
and Nicotera, P.
(1994)
J. Neural Transm. Suppl.
43,
1-11[Medline]
[Order article via Infotrieve]
|
| 20.
|
Forsythe, I. D.,
Tsujimoto, T.,
Barnes-Davies, M.,
Cuttle, M. F.,
and Takahashi, T.
(1998)
Neuron
20,
797-807[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Patil, P. G.,
Brody, D. L.,
and Yue, D. T.
(1998)
Neuron
20,
1027-1038[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Zagotta, W. N.,
Hoshi, T.,
and Aldrich, R. W.
(1990)
Science
250,
506-507[Free Full Text]
|
| 23.
|
Hoshi, T.,
Zagotta, W. N.,
and Aldrich, R. W.
(1991)
Neuron
7,
556-574
|
| 24.
|
Isacoff, E. Y.,
Jan, Y. N.,
and Jan, L. Y.
(1991)
Nature
353,
86-90[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Vassilev, P.,
Scheuer, T.,
and Catterall, W. A.
(1989)
Proc. Natl. Acad. Sci. U. S. A.
86,
8147-8151[Abstract/Free Full Text]
|
| 26.
|
Eaholtz, G.,
Scheuer, T.,
and Catterall, W. A.
(1994)
Neuron
12,
1041-1048[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Armstrong, C. M.,
and Bezanilla, F.
(1977)
J. Gen. Physiol.
70,
567-590[Abstract/Free Full Text]
|
| 28.
|
Stuhmer, W.,
Conti, F.,
Suzuki, H.,
Wang, X. D.,
Yahagi, N.,
Kubo, H.,
and Numa, S.
(1989)
Nature
339,
597-603[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Zhang, J. F.,
Ellinor, P. T.,
Aldrich, R. W.,
and Tsien, R. W.
(1994)
Nature
372,
97-100[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Bernatchez, G.,
Talwar, D.,
and Parent, L.
(1998)
Biophys. J.
75,
1727-1739[Abstract/Free Full Text]
|
| 31.
|
Zamponi, G. W.,
Soong, T. W.,
Bourinet, E.,
and Snutch, T. P.
(1996)
J. Neurosci.
16,
2430-2443[Abstract/Free Full Text]
|
| 32.
|
Hering, S.,
Aczel, S.,
Grabner, M.,
Doring, F.,
Berjukow, S.,
Mitterdorfer, J.,
Sinnegger, M. J.,
Striessnig, J.,
Degtiar, V. E.,
Wang, Z.,
and Glossmann, H.
(1996)
J. Biol. Chem.
271,
24471-24475[Abstract/Free Full Text]
|
| 33.
|
Hering, S.,
Aczel, S.,
Kraus, R. L.,
Berjukow, S.,
Striessnig, J.,
and Timin, E. N.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
13323-13328[Abstract/Free Full Text]
|
| 34.
|
Hering, S.,
Berjukow, S.,
Aczel, S.,
and Timin, E. N.
(1998)
Trends Pharmacol. Sci.
19,
439-443[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Herlitze, S.,
Hockerman, G. H.,
Scheuer, T.,
and Catterall, W. A.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
1512-1516[Abstract/Free Full Text]
|
| 36.
|
Soldatov, N. M.,
Zuhlke, R. D.,
Bouron, A.,
and Reuter, H.
(1997)
J. Biol. Chem.
272,
3560-3566[Abstract/Free Full Text]
|
| 37.
|
Choi, K. L.,
Aldrich, R. W.,
and Yellen, G.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
5092-5095[Abstract/Free Full Text]
|
| 38.
|
Kukuljan, M.,
Lebarca, P.,
and Latorre, R.
(1995)
Am. J. Physiol.
268,
C535-C556[Abstract/Free Full Text]
|
| 39.
|
Imredy, J. P.,
and Yue, D. T.
(1994)
Neuron
12,
1301-1318[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Demo, S. D.,
and Yellen, G.
(1991)
Neuron
7,
743-753[CrossRef][Medline]
[Order article via Infotrieve]
|
| 41.
|
MacKinnon, R.,
Aldrich, R. W.,
and Lee, A. W.
(1993)
Science
262,
757-759[Abstract/Free Full Text]
|
| 42.
|
Zamponi, G. W.
(1999)
J. Membr. Biol.
167,
183-192[CrossRef][Medline]
[Order article via Infotrieve]
|
| 43.
|
Hockerman, G. H.,
Johnson, B. D.,
Abbott, M. R.,
Scheuer, T.,
and Catterall, W. A.
(1997)
J. Biol. Chem.
272,
18759-18765[Abstract/Free Full Text]
|
| 44.
|
Schmid, R.,
Seydl, K.,
Baumgartner, W.,
Groschner, K.,
and Romanin, C.
(1995)
Biophys. J.
69,
1847-1857[Abstract/Free Full Text]
|
| 45.
|
Pragnell, M.,
DeWaard, M.,
Mori, Y.,
Tanabe, T.,
Snutch, T. P.,
and Campbell, K. P.
(1994)
Nature
368,
67-70[CrossRef][Medline]
[Order article via Infotrieve]
|
| 46.
|
Durrell, S. R.,
Hao, Y.,
and Guy, H. R.
(1998)
J. Struct. Biol.
73,
157-167
|
| 47.
|
Holmgren, M.,
Shin, K. S.,
and Yellen, G.
(1998)
Neuron
21,
617-621[CrossRef][Medline]
[Order article via Infotrieve]
|
| 48.
|
Liu, Y.,
Jurman, E.,
and Yellen, G.
(1996)
Neuron
16,
859-867[CrossRef][Medline]
[Order article via Infotrieve]
|
| 49.
|
Ogielska, E. M.,
Zagotta, W. N.,
Hoshi, T.,
Heinemann, S. H.,
Haab, J.,
and Aldrich, R. W.
(1995)
Biophys. J.
69,
2449-2457[Abstract/Free Full Text]
|
| 50.
|
Panyi, G.,
Sheng, Z.,
Tu, L.,
and Deutsch, C.
(1995)
Biophys. J.
69,
896-903[Abstract/Free Full Text]
|
| 51.
|
Yellen, G.,
Sodickson, D.,
Chen, T. Y.,
and Jurman, M. E.
(1994)
Biophys. J.
66,
1068-1075[Abstract/Free Full Text]
|
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike 